{"id":"https://openalex.org/W2086723809","doi":"https://doi.org/10.1161/circulationaha.113.006286","title":"High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","display_name":"High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-14","ids":{"openalex":"https://openalex.org/W2086723809","doi":"https://doi.org/10.1161/circulationaha.113.006286","mag":"2086723809","pmid":"https://pubmed.ncbi.nlm.nih.gov/24226808"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.113.006286","doi":"https://doi.org/10.1161/circulationaha.113.006286","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.113.006286","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.113.006286","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2086723809"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.113.006286","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078318313","display_name":"Ziad Hijazi","orcid":"https://orcid.org/0000-0002-7420-743X","observed_orcids":["https://orcid.org/0000-0002-7420-743X"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ziad Hijazi","raw_affiliation_strings":["Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016303786","display_name":"Agneta G Siegbahn","orcid":"https://orcid.org/0000-0003-3955-5671","observed_orcids":["https://orcid.org/0000-0003-3955-5671"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Agneta Siegbahn","raw_affiliation_strings":["Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101992953","display_name":"Ulrika Andersson","orcid":"https://orcid.org/0000-0002-5331-3348","observed_orcids":["https://orcid.org/0000-0002-5331-3348"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ulrika Andersson","raw_affiliation_strings":["Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014449865","display_name":"Christopher Bull Granger","orcid":"https://orcid.org/0000-0002-0045-3291","observed_orcids":["https://orcid.org/0000-0002-0045-3291"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher B. Granger","raw_affiliation_strings":["Duke University, Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067347864","display_name":"John Hunter Alexander","orcid":"https://orcid.org/0000-0002-1444-2462","observed_orcids":["https://orcid.org/0000-0002-1444-2462"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John H. Alexander","raw_affiliation_strings":["Duke University, Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076961983","display_name":"Dan Atar","orcid":"https://orcid.org/0000-0003-1513-8793","observed_orcids":["https://orcid.org/0000-0003-1513-8793"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dan Atar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080234509","display_name":"Bernard John Gersh","orcid":"https://orcid.org/0000-0001-5605-900X","observed_orcids":["https://orcid.org/0000-0001-5605-900X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard J. Gersh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065475423","display_name":"Puneet Mohan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Puneet Mohan","raw_affiliation_strings":["5Bristol-Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Bristol-Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058830049","display_name":"Veli\u2010Pekka Harjola","orcid":"https://orcid.org/0000-0001-5351-0811","observed_orcids":["https://orcid.org/0000-0001-5351-0811"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veli-Pekka Harjola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028734833","display_name":"John David Horowitz","orcid":"https://orcid.org/0000-0001-6883-0703","observed_orcids":["https://orcid.org/0000-0001-6883-0703"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Horowitz","raw_affiliation_strings":["#N#7University of Adelaide, Adelaide, Australia#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N#7University of Adelaide, Adelaide, Australia#N#","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044800174","display_name":"Steen Husted","orcid":"https://orcid.org/0000-0003-2020-1902","observed_orcids":["https://orcid.org/0000-0003-2020-1902"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steen Husted","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080799947","display_name":"Elaine M. Hylek","orcid":"https://orcid.org/0000-0001-8263-8304","observed_orcids":["https://orcid.org/0000-0001-8263-8304"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elaine M. Hylek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067237537","display_name":"Renato D. L\u00f3pes","orcid":"https://orcid.org/0000-0003-2999-4961","observed_orcids":["https://orcid.org/0000-0003-2999-4961","https://orcid.org/0000-0002-9454-7730"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Renato D. Lopes","raw_affiliation_strings":["Duke University, Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027213857","display_name":"John J.V. McMurray","orcid":"https://orcid.org/0000-0002-6317-3975","observed_orcids":["https://orcid.org/0000-0002-6317-3975"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John J.V. McMurray","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063591215","display_name":"Lars C. Wallentin","orcid":"https://orcid.org/0000-0003-0378-6531","observed_orcids":["https://orcid.org/0000-0003-0378-6531"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Wallentin","raw_affiliation_strings":["Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5078318313"],"corresponding_institution_ids":["https://openalex.org/I123387679"],"apc_list":null,"apc_paid":null,"fwci":8.3406,"has_fulltext":true,"cited_by_count":143,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98362788,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"129","issue":"6","first_page":"625","last_page":"634"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-sensitivity-cardiac-troponin-i","display_name":"high-sensitivity troponin I","score":0.9789999723434448},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.7400000095367432},{"id":"https://openalex.org/keywords/stroke-and-systemic-embolism","display_name":"stroke and systemic embolism","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.9629999995231628},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.996999979019165},{"id":"https://openalex.org/keywords/cha2ds2-vasc-score","display_name":"CHA2DS2-VASc score","score":0.9739999771118164},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.9739999771118164},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cardiovascular-risk-assessment","display_name":"cardiovascular risk assessment","score":0.5080000162124634},{"id":"https://openalex.org/keywords/aristotle-trial","display_name":"ARISTOTLE trial","score":0.9440000057220459},{"id":"https://openalex.org/keywords/bleeding-risk-prediction-model","display_name":"bleeding risk prediction model","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9432626962661743},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8231867551803589},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8093022108078003},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7617235779762268},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7011048793792725},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.6867468357086182},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6282430291175842},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.5610844492912292},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.46019530296325684},{"id":"https://openalex.org/C36036425","wikidata":"https://www.wikidata.org/wiki/Q7846262","display_name":"Troponin","level":3,"score":0.45899397134780884},{"id":"https://openalex.org/C115725540","wikidata":"https://www.wikidata.org/wiki/Q7846263","display_name":"Troponin I","level":3,"score":0.4196876883506775},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.34482359886169434},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.31340664625167847},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.17841649055480957},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003643","descriptor_name":"Death","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019210","descriptor_name":"Troponin I","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1161/circulationaha.113.006286","doi":"https://doi.org/10.1161/circulationaha.113.006286","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.113.006286","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.113.006286","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:24226808","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24226808","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Comparative Study"},{"id":"pmh:oai:researchbank.acu.edu.au:fhs_pub-7801","doi":null,"is_oa":false,"landing_page_url":"https://researchbank.acu.edu.au/fhs_pub/6802","pdf_url":null,"source":{"id":"https://openalex.org/S4306401783","display_name":"Research Bank (Australian Catholic University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I86695891","host_organization_name":"Australian Catholic University","host_organization_lineage":["https://openalex.org/I86695891"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Faculty of Health Sciences Publications","raw_type":"text"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/92289","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/92289","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://doi.org/10.1161/circulationaha.113.006286","raw_type":"Journal article"},{"id":"pmh:oai:eprints.gla.ac.uk:105093","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/105093/","pdf_url":null,"source":{"id":"https://openalex.org/S7407122635","display_name":"Enlighten: Publications (University of Glasgow)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I7882870","host_organization_name":"University of Glasgow","host_organization_lineage":["https://openalex.org/I7882870"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Articles"}],"best_oa_location":{"id":"doi:10.1161/circulationaha.113.006286","doi":"https://doi.org/10.1161/circulationaha.113.006286","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.113.006286","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.113.006286","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320337533","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/00py81415"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2086723809.pdf","grobid_xml":"https://content.openalex.org/works/W2086723809.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W17701363","https://openalex.org/W1966329493","https://openalex.org/W1972837977","https://openalex.org/W1976322287","https://openalex.org/W1982516608","https://openalex.org/W1988963309","https://openalex.org/W2003552474","https://openalex.org/W2016042083","https://openalex.org/W2065942755","https://openalex.org/W2066554944","https://openalex.org/W2075844027","https://openalex.org/W2076217777","https://openalex.org/W2076335162","https://openalex.org/W2089940123","https://openalex.org/W2094757280","https://openalex.org/W2098002403","https://openalex.org/W2101986300","https://openalex.org/W2106421416","https://openalex.org/W2113089341","https://openalex.org/W2114775432","https://openalex.org/W2118857793","https://openalex.org/W2120386224","https://openalex.org/W2129925362","https://openalex.org/W2131151965","https://openalex.org/W2136489990","https://openalex.org/W2142073581","https://openalex.org/W2147844281","https://openalex.org/W2151074096","https://openalex.org/W2160843187","https://openalex.org/W2162508946","https://openalex.org/W2162586165","https://openalex.org/W2164861810","https://openalex.org/W2327567334"],"related_works":["https://openalex.org/W2062608061","https://openalex.org/W2142737918","https://openalex.org/W2912758057","https://openalex.org/W2992593504","https://openalex.org/W2789232679","https://openalex.org/W4406995478","https://openalex.org/W2762933687","https://openalex.org/W1975300856","https://openalex.org/W4403817995"],"abstract_inverted_index":{"BACKGROUND:":[0],"High-sensitivity":[1],"troponin-I":[2],"(hs-TnI)":[3],"measurement":[4],"improves":[5,253],"risk":[6,244,254],"assessment":[7],"for":[8,44,179,200,210],"cardiovascular":[9],"events":[10],"in":[11,19,35,41,46,52,83,103,123,130,174,225,229,264],"many":[12],"clinical":[13,67],"settings,":[14],"but":[15],"the":[16,42,124,131,175,191,257],"added":[17],"value":[18],"atrial":[20,38,232],"fibrillation":[21,39,233],"patients":[22,40],"has":[23],"not":[24],"been":[25],"described.":[26],"METHODS":[27],"AND":[28],"RESULTS:":[29],"At":[30],"randomization,":[31],"hs-TnI":[32,64,77,126,139,154,188,236,272],"was":[33,140,155],"analyzed":[34],"14":[36],"821":[37],"Apixaban":[43],"Reduction":[45],"Stroke":[47],"and":[48,66,94,178,205,227,249,252],"Other":[49],"Thromboembolic":[50],"Events":[51],"Atrial":[53],"Fibrillation":[54],"(ARISTOTLE)":[55],"trial":[56],"comparing":[57],"apixaban":[58,263],"with":[59,143,159,218,241,266],"warfarin.":[60],"The":[61,76,235,260],"associations":[62],"between":[63],"concentrations":[65],"outcomes":[68],"were":[69,214],"evaluated":[70],"by":[71],"using":[72],"adjusted":[73,148],"Cox":[74],"analysis.":[75],"assay":[78],"detected":[79,224],"troponin":[80],"(\u22651.3":[81],"ng/L)":[82],"98.5%":[84,226],"patients,":[85],"50%":[86],"had":[87,91,96],"levels":[88,92,97,189],">5.4,":[89],"25%":[90],">10.1,":[93],"9.2%":[95,230],"\u226523":[98],"ng/L":[99],"(the":[100],"99th":[101],"percentile":[102],"healthy":[104],"individuals).":[105],"During":[106],"a":[107,242],"median":[108],"of":[109,115,231,245,262,271],"1.9":[110],"years":[111],"follow-up,":[112],"annual":[113,162],"rates":[114,163],"stroke":[116,144,201],"or":[117,145,202],"systemic":[118,146,203],"embolism":[119],"ranged":[120,164],"from":[121,165,196,206],"0.76%":[122],"lowest":[125],"quartile":[127,133],"to":[128,167,190,198,208],"2.26%":[129],"highest":[132],"(>10.1":[134],"ng/L).":[135],"In":[136],"multivariable":[137],"analysis,":[138],"significantly":[141,157],"associated":[142,158,240],"embolism,":[147,204],"hazard":[149,169,182],"ratio":[150,170,183],"1.98":[151],"(1.42-2.78),":[152],"P=0.0007.":[153],"also":[156],"cardiac":[160,211,247],"death;":[161],"0.40%":[166],"4.24%,":[168],"4.52":[171],"(3.05-6.70),":[172],"P<0.0001,":[173],"corresponding":[176],"groups,":[177],"major":[180,250],"bleeding":[181,251],"1.44":[184],"(1.11-1.86),":[185],"P=0.0250.":[186],"Adding":[187],"CHA2DS2VASc":[192,258],"score":[193],"improved":[194],"c-statistics":[195],"0.629":[197],"0.653":[199],"0.591":[207],"0.731":[209],"death.":[212],"There":[213],"no":[215],"significant":[216],"interactions":[217],"study":[219],"treatment.":[220],"CONCLUSIONS:":[221],"Troponin-I":[222],"is":[223,238],"elevated":[228],"patients.":[234],"level":[237],"independently":[239],"raised":[243],"stroke,":[246],"death,":[248],"stratification":[255],"beyond":[256],"score.":[259],"benefits":[261],"comparison":[265],"warfarin":[267],"are":[268],"consistent":[269],"regardless":[270],"levels.":[273],"CLINICAL":[274],"TRIAL":[275],"REGISTRATION":[276],"URL:":[277],"http://www.clinicaltrials.gov.":[278],"Unique":[279],"identifier:":[280],"NCT00412984.":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2086723809","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":19},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
